179 related articles for article (PubMed ID: 36532308)
21. Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma.
Antwi SO; Habboush YY; Chase LA; Lee DD; Patel T
Ann Hepatol; 2018 Oct; 17(6):969-979. PubMed ID: 30600299
[TBL] [Abstract][Full Text] [Related]
22. Loco-regional treatment of hepatocellular carcinoma.
Lencioni R
Hepatology; 2010 Aug; 52(2):762-73. PubMed ID: 20564355
[TBL] [Abstract][Full Text] [Related]
23. The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinoma.
D'Avola D; Granito A; Torre-Aláez M; Piscaglia F
J Hepatol; 2022 May; 76(5):1185-1198. PubMed ID: 34793869
[TBL] [Abstract][Full Text] [Related]
24. An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma.
Bimonte S; Barbieri A; Palaia R; Leongito M; Albino V; Piccirillo M; Arra C; Izzo F
Infect Agent Cancer; 2015; 10():9. PubMed ID: 25755676
[TBL] [Abstract][Full Text] [Related]
25. Loco-regional treatment of hepatocellular carcinoma in the era of molecular targeted therapies.
Lencioni R
Oncology; 2010 Jul; 78 Suppl 1():107-12. PubMed ID: 20616592
[TBL] [Abstract][Full Text] [Related]
26. Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects.
Lencioni R; Crocetti L; De Simone P; Filipponi F
Transpl Int; 2010 Jul; 23(7):698-703. PubMed ID: 20492618
[TBL] [Abstract][Full Text] [Related]
27. Transarterial Therapies for Hepatocellular Carcinoma.
Lanza E; Donadon M; Poretti D; Pedicini V; Tramarin M; Roncalli M; Rhee H; Park YN; Torzilli G
Liver Cancer; 2016 Nov; 6(1):27-33. PubMed ID: 27995085
[TBL] [Abstract][Full Text] [Related]
28. Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy.
Byrne TJ; Rakela J
World J Transplant; 2016 Jun; 6(2):306-13. PubMed ID: 27358775
[TBL] [Abstract][Full Text] [Related]
29. Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts.
Molvar C; Lewandowski R
Semin Intervent Radiol; 2015 Dec; 32(4):388-97. PubMed ID: 26622103
[TBL] [Abstract][Full Text] [Related]
30. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
Wehrenberg-Klee E; Gandhi RT; Ganguli S
Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
[TBL] [Abstract][Full Text] [Related]
31. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
Trials; 2012 Aug; 13():144. PubMed ID: 22913492
[TBL] [Abstract][Full Text] [Related]
32. Impact of geographic disparity on liver allocation for hepatocellular cancer in the United States.
Kadry Z; Schaefer EW; Uemura T; Shah AR; Schreibman I; Riley TR
J Hepatol; 2012 Mar; 56(3):618-25. PubMed ID: 22027581
[TBL] [Abstract][Full Text] [Related]
33. New treatment modalities for hepatocellular cancer.
Mauer K; O'Kelley R; Podda N; Flanagan S; Gadani S
Curr Gastroenterol Rep; 2015 May; 17(5):442. PubMed ID: 25869473
[TBL] [Abstract][Full Text] [Related]
34. Radiation therapy for hepatocellular carcinoma: from palliation to cure.
Hawkins MA; Dawson LA
Cancer; 2006 Apr; 106(8):1653-63. PubMed ID: 16541431
[TBL] [Abstract][Full Text] [Related]
35. Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides.
Khan AR; Wei X; Xu X
J Hepatocell Carcinoma; 2021; 8():1089-1115. PubMed ID: 34522691
[TBL] [Abstract][Full Text] [Related]
36. Multimodality treatment of hepatocellular carcinoma.
Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Lin ZY; Lu JZ; Liu KD; Ye SL; Yang BH
J Gastroenterol Hepatol; 1998 Nov; 13(S3):S315-S319. PubMed ID: 28976647
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.
Vincenzi B; Di Maio M; Silletta M; D'Onofrio L; Spoto C; Piccirillo MC; Daniele G; Comito F; Maci E; Bronte G; Russo A; Santini D; Perrone F; Tonini G
PLoS One; 2015; 10(7):e0133488. PubMed ID: 26230853
[TBL] [Abstract][Full Text] [Related]
38. Tumor markers for early diagnosis for brain metastasis of hepatocellular carcinoma: A case series and literature review for effective loco-regional treatment.
Kamimura K; Kobayashi Y; Takahashi Y; Abe H; Kumaki D; Yokoo T; Kamimura H; Sakai N; Sakamaki A; Abe S; Takamura M; Kawai H; Yamagiwa S; Terai S
Cancer Biol Ther; 2017 Feb; 18(2):79-84. PubMed ID: 28045618
[TBL] [Abstract][Full Text] [Related]
39. Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom.
Palmer DH; Hussain SA; Smith AJ; Hargreaves S; Ma YT; Hull D; Johnson PJ; Ross PJ
Br J Cancer; 2013 Aug; 109(4):888-90. PubMed ID: 23880824
[TBL] [Abstract][Full Text] [Related]
40. Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?
Savic LJ; Chapiro J; Duwe G; Geschwind JF
Hepat Oncol; 2016 Jan; 3(1):19-28. PubMed ID: 26989470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
